BioCardia, Inc.
BCDA
$1.96
-$0.145-6.91%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.81% | 32.52% | 51.93% | 35.25% | 31.57% |
| Total Depreciation and Amortization | -25.00% | -23.81% | -19.05% | -13.64% | -4.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.56% | -22.92% | -39.80% | -18.49% | -21.07% |
| Change in Net Operating Assets | -603.75% | -457.21% | 153.79% | -24.02% | 76.88% |
| Cash from Operations | -39.01% | -8.25% | 58.36% | 40.23% | 38.24% |
| Capital Expenditure | -- | -- | -50.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -50.00% | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.10% | 7,723.91% | -31.67% | 500.82% | -65.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 89.43% | -617.33% | 40.95% | 50.00% | -21.39% |
| Cash from Financing | -98.66% | 10,655.17% | -31.30% | 2,050.00% | -69.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -249.59% | 242.06% | 185.51% | 93.85% | -205.17% |
